CoverageForm 410-K10-Q8-K13D13G13F

Apogee Therapeutics, Inc.

APGECIK 0001974640 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 2, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Mild negative shiftFull-doc fallback
Full filing:tone -0.0139Δ-0.002188% similar+537/-600

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Apogee Therapeutics, Inc.

Showing 1-5 of 15

Page 1 of 3Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Apogee Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Dambkowski Carl4835%-12.8%-8.9%+41.6%-92.4%
2Henderson Jane1631%-8.7%-11.3%+12.8%-27.3%
3Fairmount Funds Management LLC40%-7.7%-5.8%-5.8%-13.5%
4Fairmount Healthcare Fund II L.P.40%-7.7%-5.8%-5.8%-13.5%
5Harwin Peter Evan40%-7.7%-5.8%-5.8%-13.5%
6Kiselak Tomas40%-7.7%-5.8%-5.8%-13.5%
7Fairmount Healthcare Co-Invest II L.P.30%-5.8%-5.8%-5.8%-5.8%
8Fairmount Healthcare Fund L.P.30%-5.8%-5.8%-5.8%-5.8%
9Henderson Michael Thomas3444%-1.8%-4.5%+41.6%-49.5%

All filings

88 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue